Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -0.5436
March 31, 2026 -0.5504
December 31, 2025 -0.5632
September 30, 2025 -0.5766
June 30, 2025 -0.5892
March 31, 2025 -0.6059
December 31, 2024 -0.6206
September 30, 2024 -0.6301
June 30, 2024 -0.647
March 31, 2024 -0.6641
December 31, 2023 -0.6819
September 30, 2023 -0.7038
June 30, 2023 -0.726
March 31, 2023 -0.749
December 31, 2022 -0.5596
September 30, 2022 -0.569
June 30, 2022 -0.5815
March 31, 2022 -0.5768
December 31, 2021 -0.5692
September 30, 2021 -0.5782
June 30, 2021 -0.5797
March 31, 2021 -0.5982
December 31, 2020 -0.6197
September 30, 2020 -0.6245
June 30, 2020 -0.6488
Date Value
March 31, 2020 -0.6627
December 31, 2019 -0.6953
September 30, 2019 -0.7443
June 30, 2019 -0.7844
March 31, 2019 -0.5878
December 31, 2018 -0.5966
September 30, 2018 -0.6365
June 30, 2018 -0.7151
March 31, 2018 -0.7372
December 31, 2017 -0.75
September 30, 2017 -0.7705
June 30, 2017 -0.7709
March 31, 2017 -0.7692
December 31, 2016 -0.7947
September 30, 2016 -0.8113
June 30, 2016 -0.8447
March 31, 2016 -0.8502
December 31, 2015 -0.882
September 30, 2015 -0.8575
June 30, 2015 -0.8878
March 31, 2015 -0.9182
December 31, 2014 -0.9718
September 30, 2014 -0.9909
June 30, 2014 -0.9445
March 31, 2014 -0.9887

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Medifast, Inc. 0.1406
Integrated BioPharma, Inc. 0.1742
Nevis Brands, Inc. --
Functional Brands, Inc. -2.026
Cyanotech Corp. 1.424